BRANDON ROSCOE: Open Payments
NPI 1639394034 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$358 in 16 payments from 9 companies in 2025. Trend: 2023 $293 · 2024 $300 · 2025 $358
Food & beverage: $358
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 4 | $90 |
| Otsuka America Pharmaceutical, Inc. | 4 | $77 |
| Boston Scientific Corporation | 2 | $70 |
| Dexcom, Inc. | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $19 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $15 |
Products named: SUBLOCADE, REXULTI, WATCHMAN FLX, Dexcom G6 Transmitter, LEQVIO, NUZYRA, Veozah, ONPATTRO.
Industry payments across PA — which companies pay providers there.
